Clinical Trials Logo

Clinical Trial Details — Status: Withdrawn

Administrative data

NCT number NCT01011400
Other study ID # 121-09
Secondary ID
Status Withdrawn
Phase N/A
First received November 10, 2009
Last updated August 27, 2013
Start date November 2009
Est. completion date December 2011

Study information

Verified date August 2013
Source Meir Medical Center
Contact n/a
Is FDA regulated No
Health authority Israel: Ethics Commission
Study type Observational

Clinical Trial Summary

Abnormal enlargement of the clitoris in fetal life may be a sign for different pathologies. To the investigators knowledge there is no published nomogram of the clitoris size through gestation and it's assessment is usually subjective. The purpose of this study is to create a nomogram of clitorial size through gestation by measuring its size in fetuses of different age in the second and third trimester.


Recruitment information / eligibility

Status Withdrawn
Enrollment 0
Est. completion date December 2011
Est. primary completion date December 2011
Accepts healthy volunteers Accepts Healthy Volunteers
Gender Female
Age group 14 Weeks to 37 Weeks
Eligibility Inclusion Criteria:

- well dated pregnancy

- singleton pregnancy

- female fetus

- appropriate for gestational age

Exclusion Criteria:

- small for gestational age

- other fetal anomalies

- maternal conditions that can cause exposure of the fetus to high androgen environment

Study Design

Observational Model: Case-Only, Time Perspective: Prospective


Related Conditions & MeSH terms


Locations

Country Name City State
Israel Meir Medical Center Kfar Saba

Sponsors (1)

Lead Sponsor Collaborator
Meir Medical Center

Country where clinical trial is conducted

Israel,